{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T13:52:04Z","timestamp":1655301124594},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,10,1]]},"DOI":"10.1093\/ndt\/14.10.2469","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:27:38Z","timestamp":1027722458000},"page":"2469-2471","source":"Crossref","is-referenced-by-count":15,"title":["Thrombotic microangiopathy in a patient with chronic myelocytic leukaemia treated with \u03b1-interferon"],"prefix":"10.1093","volume":"14","author":[{"given":"Henri","family":"Vacher-Coponat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Opris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Robert","family":"Harle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Veit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Olmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,10]]},"reference":[{"key":"key\n\t\t\t\t20180202235913_R1","doi-asserted-by":"crossref","unstructured":"Vial T, Descotes J. Clinical toxicity of the interferons. Drug Safety1994; 10: 115\u2013150","DOI":"10.2165\/00002018-199410020-00003"},{"key":"key\n\t\t\t\t20180202235913_R2","doi-asserted-by":"crossref","unstructured":"Dimitrov Y, Heibel F, Marcellin L, Chantrel F, Moulin B, Hannedouche T. Acute renal failure and nephrotic syndrome with alpha interferon therapy. Nephrol Dial Transplant1997; 12: 200\u2013203","DOI":"10.1093\/ndt\/12.1.200"},{"key":"key\n\t\t\t\t20180202235913_R3","doi-asserted-by":"crossref","unstructured":"Stratta P, Canavese C, Dogliani M et al. Hemolytic\u2013uremic syndrome during recombinant alpha interferon treatment for hairy cell leukemia. Renal Failure1993; 15: 559\u2013562","DOI":"10.3109\/08860229309054974"},{"key":"key\n\t\t\t\t20180202235913_R4","unstructured":"Jadoul M, Piessevaux H, Ferrant A, Cosyns JP, Van Ypersele de Strihou C. Renal thrombotic microangiopathy in patients with chronic myelogenous leukemia treated with interferon \u03b1-2b. Nephrol Dial Transplant1995; 10: 111\u2013113"},{"key":"key\n\t\t\t\t20180202235913_R5","doi-asserted-by":"crossref","unstructured":"Cardineau E, Le Goff C, Henri P et al. N\u00e9phropathies secondaires aux interf\u00e9rons alpha: \u00e0 propos de deux observations. Rev Med Intern1995; 16: 691\u2013695","DOI":"10.1016\/0248-8663(96)80773-9"},{"key":"key\n\t\t\t\t20180202235913_R6","doi-asserted-by":"crossref","unstructured":"Harvey M, Rosenfeld D, Davies D, Hall BM. Recombinant interferon alpha and hemolytic uremic syndrome: cause or coincidence? Am J Hematol1994; 46: 152\u2013153","DOI":"10.1002\/ajh.2830460220"},{"key":"key\n\t\t\t\t20180202235913_R7","doi-asserted-by":"crossref","unstructured":"Honda K, Ando A, Endo M et al. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myelocytic leukemia. Am J Kidney Dis1997; 30: 123\u2013130","DOI":"10.1016\/S0272-6386(97)90575-8"},{"key":"key\n\t\t\t\t20180202235913_R8","doi-asserted-by":"crossref","unstructured":"Remuzzi G, Garella S. HUS and TTP: variable expression of a single entity. Kidney Int1987; 32: 292\u2013308","DOI":"10.1038\/ki.1987.206"},{"key":"key\n\t\t\t\t20180202235913_R9","doi-asserted-by":"crossref","unstructured":"Kramer P, Ten Kate FWJ, Bijnen AB. Recombinant leukocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients. Lancet1984; i: 989\u2013990","DOI":"10.1016\/S0140-6736(84)92327-4"},{"key":"key\n\t\t\t\t20180202235913_R10","doi-asserted-by":"crossref","unstructured":"R\u00f6nnblom LE, Alm GV, \u00d6berg KE. Autoimmunity after alpha-interferon therapy for malignant carotid tumors. Ann Intern Med1991; 115: 178\u2013183","DOI":"10.7326\/0003-4819-115-3-178"},{"key":"key\n\t\t\t\t20180202235913_R11","unstructured":"Neild GH. Hemolytic uremic syndrome\/thrombotic thrombocytopenic purpura: pathophysiology and treatment. Kidney Int1998; 53 [Suppl 64]: S45\u2013S49"},{"key":"key\n\t\t\t\t20180202235913_R12","unstructured":"Piette JC, PapoT. Potential role for antiphospholipid antibodies in renal thrombotic microangiopathy induced by interferon-alpha. Nephrol Dial Transplant1995; 10: 1781"},{"key":"key\n\t\t\t\t20180202235913_R13","doi-asserted-by":"crossref","unstructured":"Morschlauser F. Glomerular injury in chronic myelomonocytic leukemia. Leuk Lymphoma1995; 18: 479\u2013483","DOI":"10.3109\/10428199509059648"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/14\/10\/2469\/23770932\/142469.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T06:13:51Z","timestamp":1517638431000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/14\/10\/2469\/1806033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10,1]]},"references-count":13,"journal-issue":{"issue":"10","published-online":{"date-parts":[[1999,10]]},"published-print":{"date-parts":[[1999,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/14.10.2469","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[1999,10]]},"published":{"date-parts":[[1999,10,1]]}}}